FDA receives data from Pfizer for authorization of Covid vaccine booster for the wider population BioNTech and Pfizer have announced their submission of their early-stage clinical trial data to the FDA as they seek authorization for a Covid-19 booster shot in the US Currently, Federal health officials are not recommending any type of booster doses… Continue reading Business News – 08-16-2021